Catalysts for $PHAT
16 tracked
Oct 29, 2026
earnings
Phathom Pharmaceuticals, Inc. earnings
Phathom Pharmaceuticals, Inc.
→
Nov 6, 2025
approval
VOQUEZNA (VONOPRAZAN FUMARATE) — FDA approval
vonoprazan fumarate
→
Oct 31, 2025
approval
VOQUEZNA DUAL PAK (AMOXICILLIN) — FDA approval
amoxicillin + vonoprazan fumarate
→
Oct 31, 2025
approval
VOQUEZNA TRIPLE PAK (AMOXICILLIN) — FDA approval
amoxicillin + clarithromycin + vonoprazan
→
Jun 12, 2025
approval
VOQUEZNA DUAL PAK (AMOXICILLIN) — FDA approval
amoxicillin + vonoprazan fumarate
→
Jun 12, 2025
approval
VOQUEZNA TRIPLE PAK (AMOXICILLIN) — FDA approval
amoxicillin + clarithromycin + vonoprazan
→
Jul 31, 2024
approval
VOQUEZNA DUAL PAK (AMOXICILLIN) — FDA approval
amoxicillin + vonoprazan fumarate
→
Jul 31, 2024
approval
VOQUEZNA TRIPLE PAK (AMOXICILLIN) — FDA approval
amoxicillin + clarithromycin + vonoprazan
→
Jul 17, 2024
approval
VOQUEZNA (VONOPRAZAN FUMARATE) — FDA approval
vonoprazan fumarate
→
May 1, 2024
approval
VOQUEZNA DUAL PAK (AMOXICILLIN) — FDA approval
amoxicillin + vonoprazan fumarate
→
May 1, 2024
approval
VOQUEZNA TRIPLE PAK (AMOXICILLIN) — FDA approval
amoxicillin + clarithromycin + vonoprazan
→
Nov 1, 2023
approval
VOQUEZNA (VONOPRAZAN FUMARATE) — FDA approval
vonoprazan fumarate
→
Aug 16, 2023
approval
VOQUEZNA DUAL PAK (AMOXICILLIN) — FDA approval
amoxicillin + vonoprazan fumarate
→
Aug 16, 2023
approval
VOQUEZNA TRIPLE PAK (AMOXICILLIN) — FDA approval
amoxicillin + clarithromycin + vonoprazan
→
May 3, 2022
approval
VOQUEZNA DUAL PAK (AMOXICILLIN) — FDA approval
amoxicillin + vonoprazan fumarate
→
May 3, 2022
approval
VOQUEZNA TRIPLE PAK (AMOXICILLIN) — FDA approval
amoxicillin + clarithromycin + vonoprazan
→